About the Authors

Yosef Buganim

Contributed equally to this work with: Yosef Buganim, Ido Goldstein

Affiliation Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel

Ido Goldstein

Contributed equally to this work with: Yosef Buganim, Ido Goldstein

Affiliation Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel

Doron Lipson

Affiliation Department of Computer Sciences, Technion—Institute of Technology, Haifa, Israel

Michael Milyavsky

Affiliation Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel

Sylvie Polak-Charcon

Affiliation Department of Pathology, The Chaim Sheba Medical Center, Tel-Hashomer, Ramat Gan, Israel

Corine Mardoukh

Affiliation Department of Pathology, The Chaim Sheba Medical Center, Tel-Hashomer, Ramat Gan, Israel

Hilla Solomon

Affiliation Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel

Eyal Kalo

Affiliation Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel

Shalom Madar

Affiliation Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel

Ran Brosh

Affiliation Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel

Marina Perelman

Affiliation Department of Pathology, The Chaim Sheba Medical Center, Tel-Hashomer, Ramat Gan, Israel

Roy Navon

Affiliation Agilent Technologies, Tel-Aviv, Israel

Naomi Goldfinger

Affiliation Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel

Iris Barshack

Affiliation Department of Pathology, The Chaim Sheba Medical Center, Tel-Hashomer, Ramat Gan, Israel

Zohar Yakhini

Affiliations Department of Computer Sciences, Technion—Institute of Technology, Haifa, Israel, Agilent Technologies, Tel-Aviv, Israel

Varda Rotter

varda.rotter@weizmann.ac.il

Affiliation Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel

Competing Interests

Two of the authors of this manuscript (Dr. Yakhini and Mr. Navon) are employed by Agilent Technologies. Dr. Yakhini designed the probes that were used in the CGH array and analyzed the results. Mr. Navon analyzed the BPTF gene dosage in the NCI-60 cell lines. Agilent Technologies received full payment for Dr. Yakhini's and Mr. Navon's contribution to the manuscript. The authors declare that no patents and/or products in development or marketed products are associated with this manuscript.

Author Contributions

Conceived and designed the experiments: YB IG MM IB ZY VR. Performed the experiments: YB IG MM SPC CM HS EK SM RB NG. Analyzed the data: YB IG DL SPC MP RN ZY. Contributed reagents/materials/analysis tools: YB IG. Wrote the paper: YB IG.